Home Article AirAvant Medical shares research findings

AirAvant Medical shares research findings

AirAvant Medical shares research findings

Also Noted

Default Author Head Shot

By HME News Staff

Updated Fri May 31, 2019

DEERFIELD BEACH, Fla. - AirAvant Medical will share research findings on the efficacy and safety of its Bongo Rx at the SLEEP 2019 conference, June 8-12 in San Antonio. “Long-term CPAP compliance continues to range from 30% to 70%, but we believe the Bongo Rx can help level the playing field for those with mild to moderate sleep apnea,” said Ron Richard, co-founder and director. “Not only can this product work for non-compliant patients, it can be a great supplemental option for compliant patients that travel.” The Bongo Rx is an expiratory positive airway pressure (EPAP) device for patients with mild to moderate sleep apnea that's available by prescription. The newly formed AirAvant Medical comprises the former partners of InnoMed Technology, and Ron Richard, formerly of ResMed and SeQual Technologies. InnoMed's past achievements include the Nasal-Aire, Hybrid and Aloha line of CPAP interfaces.

Comments

To comment on this post, please log in to your account or set up an account now.